Results 161 to 170 of about 567,668 (313)

A Comparison of Short and Long-Term Acting Dopamine Agonists in the Treatment of Parkinson's Disease with Respect to the Side Effects of Impulse Control Disorder. [PDF]

J Clin Pract Res
Oruc HG, Yildiz BT.
europepmc   +1 more source

Clinical management and outcome of 36 invasive prolactinomas treated with dopamine agonist

, 2010
Moon Sool Yang, Jae Won Hong, Seung‐Koo Lee, Eun Jig Lee, Sun Ho Kim   +4 more
openalex   +2 more sources

Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer

Proceedings of the National Academy of Sciences of the United States of America, 2015
J. Bonaventura, Gemma Navarro, Verònica Casadó-Anguera, Karima Azdad, W. Rea, E. Moreno, Marc Brugarolas, J. Mallol, E. Canela, C. Lluis, Antonio Cortés, N. Volkow, S. Schiffmann, S. Ferré, V. Casadó   +14 more
semanticscholar   +1 more source

Targeting the noradrenergic‐metabolic axis: A new strategy for sugar‐induced depression subtypes

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Lifestyle is closely related to major depressive disorder (MDD). Given the growing focus on the impact of diet on mental health, this study examined how dietary habits affect the pathophysiology of MDD. Experimental Approach Health check‐up data were analysed. Mice received sucrose under chronic unpredictable mild stress
Takatoshi Sakata, Kazuo Kunisawa, Masaya Hasegawa, Yumiko Seto, Aoi Ogawa, Hitomi Kurahashi, Yasuko Yamamoto, Masao Takemura, Hidetoshi Matunami, Tomoya Sugai, Noriki Kutsumura, Kuniaki Saito, Toshitaka Nabeshima, Akihiro Mouri   +13 more
wiley   +1 more source

Pulmonary Fibrosis in a Patient With a Prolactinoma on Dopamine Agonists: Coincidence or Consequence. [PDF]

JCEM Case Rep
Shah R, Bal A, Arjunan D, Ghosh J, Grossman AB, Dutta P.   +5 more
europepmc   +1 more source

Vesicular glutamate transporter VGLUT2 expression emerges in substantia nigra dopamine neurons in mouse models of parkinsonism in the absence of neurodegeneration

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Subsets of midbrain dopamine (DA) neurons express the vesicular glutamate transporter VGLUT2 and can release the excitatory neurotransmitter glutamate. VGLUT2+ DA neurons of the substantia nigra pars compacta (SNc) were shown to be more resistant to neurodegeneration in animal models of Parkinson's disease (PD ...
Sivakumar Srinivasan, Christian Pifl, Thomas Steinkellner   +2 more
wiley   +1 more source

Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease.

PLoS Biology, 2005
Brain dopamine is critically involved in movement control, and its deficiency is the primary cause of motor symptoms in Parkinson disease. Here we report development of an animal model of acute severe dopamine deficiency by using mice lacking the ...
doaj   +1 more source

Inhibitory effects of dopamine agonists on pain-responsive neurons in the central nucleus of the amygdala. [PDF]

J Neurophysiol
Heuermann RJ, Gereau RW.
europepmc   +1 more source

Long-term Outcome of Microscopic Transsphenoidal Surgery for Prolactinomas as an Alternative to Dopamine Agonists. [PDF]

J Korean Med Sci, 2021
Park K, Park KH, Park HR, Lee JM, Kim YH, Kim DY, Won TB, Kong SH, Kim JH, Shin CS, Paek SH.   +10 more
europepmc   +1 more source

Effect of Dopamine Agonist Treatment on Glycemic Control in Patients with Lipodystrophy

İlgın Yıldırım Şimşir, Su Özgür, Utku Erdem Soyaltın, Şevki Çetinkalp   +3 more
openalex   +1 more source